Clinical Trials Browser

Phase 1/2 × uproleselan × Clear all

NCT02306291 2019-05-17

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Phase 1/2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute